How to buy Mereo BioPharma Group (MREO) shares in the UK

Mereo Biopharma Group is a company dedicated to providing new therapies to patients diagnosed with cancer and other diseases. In April 2019, Mereo Biopharma merged with Oncomed Pharmaceuticals.

Mereo BioPharma Group PLC ADR (MREO) is a publicly traded biotechnology business based in the US. In the week up to 25 September Mereo BioPharma Group shares plunged 20.59% to a closing position of $0.8417. However, over the last 12 months, Mereo BioPharma Group's share price has risen by 32.08% from $2.4. Mereo BioPharma Group is listed on the NASDAQ and employs 49 staff. All prices are listed in US Dollars.

How to buy shares in Mereo BioPharma Group

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MREO in this case.
  5. Research Mereo BioPharma Group shares. The platform should provide the latest information available.
  6. Buy your Mereo BioPharma Group shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x Mereo BioPharma Group shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £1.44
£288.73 total
Capital at risk
IG Share Dealing logo £0 £250 £10.54
£297.84 total
Capital at risk
Fineco logo £0 No minimum £2.87
£290.17 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £14.82
£302.12 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.29
£287.58 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £12.30
£299.60 total
Capital at risk
Stake logo £0 £50 £1.44
£288.73 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £13.09
£300.39 total
Capital at risk

Full comparison of share dealing platforms

Mereo BioPharma Group share price (NASDAQ:MREO)

Use our graph to track the performance of MREO stocks over time.

Mereo BioPharma Group price performance over time

Historical closes compared with the last close of $3.17

1 week (2022-09-22) 263.91%
1 month (2022-08-29) 138.35%
3 months (2022-06-29) 134.81%
1 year (2021-09-27) 27.82%
2 years (2020-09-29) 24.31%
3 years (2019-09-27) 5.67%

Is it a good time to buy Mereo BioPharma Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Mereo BioPharma Group shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Mereo BioPharma Group under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Mereo BioPharma Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Mereo BioPharma Group shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Mereo BioPharma Group shares at a glance

Information last updated 2021-07-02.
Open$3.15
High$3.2
Low$3.065
Close$3.17
Previous close$3.15
Change$0.02
Change %0.6349%
Volume1,949,695
Information last updated 2022-09-26.
52-week range$0.301 - $2.59
50-day moving average$1.2216
200-day moving average$1.1493
Wall St. target price$577.32
PE ratio8.417
Dividend yield$0 (0%)
Earnings per share (TTM)$0.1

Do Mereo BioPharma Group shares pay dividends?

We're not expecting Mereo BioPharma Group to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Mereo BioPharma Group had its IPO on 24 April 2019). However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Mereo BioPharma Group's shares have ranged in value from as little as $0.301 up to $2.59. A popular way to gauge a stock's volatility is its "beta".

MREO.US volatility(beta: 0.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mereo BioPharma Group's is 0.6112. This would suggest that Mereo BioPharma Group's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site